Serina Therapeutics, Inc. ( SER) - Key Metrics
SER Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.39 | -$0.41 | -$0.41 |
| 2026Q1 | $0 | -$0.57 | -$0.38 | -$0.38 |
| 2025Q4 | $0 | -$0.33 | -$0.59 | -$0.59 |
| 2025Q3 | $0 | -$0.44 | -$0.37 | -$0.37 |
| 2025Q2 | $0.01 | -$0.64 | -$0.37 | -$0.37 |
SER Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -39.95% | -0.88 |
| 2026Q1 | 0% | -0.84 |
| 2025Q4 | 0% | -1.54 |
| 2025Q3 | 0% | -3.05 |
| 2025Q2 | 0% | -2.41 |
SER Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -21.03% | 7.99% |
| 2026Q1 | -19.65% | 0% |
| 2025Q4 | -31.00% | 0% |
| 2025Q3 | -6.97% | 0% |
| 2025Q2 | -6.09% | 0% |
SER
Price: $1.77
52 week price:
Earnings Per Share: -1.87 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 29.4 million